Cirrhosis and its complications:Evidence based treatment

作者: Salman Nusrat , Muhammad S Khan , Javid Fazili , Mohammad F Madhoun , None

DOI: 10.3748/WJG.V20.I18.5442

关键词:

摘要: Cirrhosis results from progressive fibrosis and is the final outcome of all chronic liver disease. It among ten leading causes death in United States. can result portal hypertension and/or hepatic dysfunction. Both these either alone or combination lead to many complications, including ascites, varices, encephalopathy, hepatocellular carcinoma, hepatopulmonary syndrome, coagulation disorders. its complications not only impair quality life but also decrease survival. Managing patients with cirrhosis be a challenge requires an organized systematic approach. Increasing physicians’ knowledge about prevention treatment potential important improve patient outcomes. A literature search published data was performed provide comprehensive review regarding management complications.

参考文章(232)
Càndid Villanueva, Alan Colomo, Alba Bosch, Mar Concepción, Virginia Hernandez-Gea, Carles Aracil, Isabel Graupera, María Poca, Cristina Alvarez-Urturi, Jordi Gordillo, Carlos Guarner-Argente, Miquel Santaló, Eduardo Muñiz, Carlos Guarner, Transfusion strategies for acute upper gastrointestinal bleeding. The New England Journal of Medicine. ,vol. 368, pp. 11- 21 ,(2013) , 10.1056/NEJMOA1211801
Florence Wong, Mauro Bernardi, R Balk, B Christman, Richard Moreau, G Garcia-Tsao, D Patch, G Soriano, J Hoefs, Miquel Navasa, Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club Gut. ,vol. 54, pp. 718- 725 ,(2005) , 10.1136/GUT.2004.038679
Atif Zaman, Thomas Becker, Jodi Lapidus, Kent Benner, Risk Factors for the Presence of Varices in Cirrhotic Patients Without a History of Variceal Hemorrhage Archives of Internal Medicine. ,vol. 161, pp. 2564- 2570 ,(2001) , 10.1001/ARCHINTE.161.21.2564
Bruce A Runyon, None, Management of adult patients with ascites due to cirrhosis: an update. Hepatology. ,vol. 49, pp. 2087- 2107 ,(2009) , 10.1002/HEP.22853
Puneeta Tandon, Guadalupe Garcia-Tsao, Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Seminars in Liver Disease. ,vol. 28, pp. 26- 42 ,(2008) , 10.1055/S-2008-1040319
Marta Casado, Jaume Bosch, Juan Carlos García-Pagán, Conxita Bru, Rafael Bañares, Juan Carlos Bandi, Angels Escorsell, José Manuel Rodríguez-Láiz, Rosa Gilabert, Faust Feu, Carlos Schorlemer, Antonio Echenagusia, Joan Rodés, Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings Gastroenterology. ,vol. 114, pp. 1296- 1303 ,(1998) , 10.1016/S0016-5085(98)70436-6
R C BENYON, Is liver fibrosis reversible Gut. ,vol. 46, pp. 443- 446 ,(2000) , 10.1136/GUT.46.4.443
P Angeli, S Fasolato, E Mazza, L Okolicsanyi, G Maresio, E Velo, A Galioto, F Salinas, M D'Aquino, A Sticca, A Gatta, Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial Gut. ,vol. 59, pp. 98- 104 ,(2010) , 10.1136/GUT.2008.176495
A. Sanyal, Z. M. Younossi, N. M. Bass, K. D. Mullen, F. Poordad, R. S. Brown, R. P. Vemuru, M. Mazen Jamal, S. Huang, K. Merchant, E. Bortey, W. P. Forbes, Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 853- 861 ,(2011) , 10.1111/J.1365-2036.2011.04808.X
Michael Malinchoc, Patrick S. Kamath, Fredric D. Gordon, Craig J. Peine, Jeffrey Rank, Pieter C.J. ter Borg, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. ,vol. 31, pp. 864- 871 ,(2000) , 10.1053/HE.2000.5852